Cabio Biotech
CABIO Biotech established in 2004, was listed on the Shanghai Stock Exchange's STAR Market in 2019 (Stock Code: 688089). The company leverages synthetic biology as its foundational technology, with a technological platform that encompasses key modules such as strain-directed breeding, precise cellular regulation, and efficient separation and purification. Through innovative cell factory preparation methods and sustainable bio-intelligent manufacturing, CABIO provides high-quality functional ingredients, bio-based products, and innovative solutions to global customers.
7-day free trial · no credit card
Verified contacts
11
available on Kipplo
LinkedIn employees
26
501 to 1000 range
Open roles
—
no listings
Distinct roles
9
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 11 verified contacts at Cabio Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
11 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Cabio Biotech
9 distinct titles indexed · top 9 shown.
- 2strategic planning manager
- 1business development manager
- 1cso
- 1customer manager
- 1digital marketing supervisor
- 1general management
- 1manager of sales
- 1r & d director
- 1senior application r & d engineer
Sign up to unlock all 11 contacts at Cabio Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 11 verified contacts at Cabio Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.